WINDTREE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3 USD | +3.09% |
|
-8.81% | -76.82% |
| May. 15 | Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 17 | Windtree Therapeutics Seeks Acquisitions | CI |
Evolution of the average Target Price on Windtree Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
f57536e255442a027.kLu_ewGSAb7K0Aw5Kqi7yhYN8BrmvLgSfxmY5ekiqf4.5szQP0rob-eggENxSf6MvHpBkWyOzYl4LH71ptha3dPhi_IyOKZKh6DhNA~8e8c12d8364e94347fbff5c11776729a
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3
USD
Average target price
18
USD
Spread / Average Target
+500.00%
High Price Target
18
USD
Spread / Highest target
+500.00%
Low Price Target
18
USD
Spread / Lowest Target
+500.00%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Windtree Therapeutics, Inc.
| Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- WINT Stock
- Consensus Windtree Therapeutics, Inc.
